Abstract

OBJECTIVE: To review the evidence for antithrombotic therapy in patients with nonrheumatic atrial fibrillation. QUALITY OF EVIDENCE: Five primary prevention trials and one secondary prevention trial compare antithrombotic therapy with placebo or no treatment. Two trials also determine the efficacy and safety of acetylsalicylic acid.

Authors

Turpie AG; Connolly SJ

Journal

Canadian Family Physician, Vol. 42, , pp. 1341–1345

Publication Date

7 1996

ISSN

0008-350X

Associated Experts

Alexander Graham Gri Turpie

Professor Emeritus, Faculty of Health Sciences

Visit profile

Labels

Fields of Research (FoR)

4203 Health services and systems 42 Health Sciences

Medical Subject Headings (MeSH)

Anticoagulants Aspirin Atrial Fibrillation Cerebrovascular Disorders Humans Platelet Aggregation Inhibitors Primary Prevention Risk Factors Treatment Outcome Warfarin